Berberine improves cardiac insufficiency and cardiac hypertrophy in DCM mice by regulating SIRT3‐mediated lipid metabolism, promoting lipophagy, and reducing high glucose‐induced cellular lipotoxicity [83]. Here, SIRT3 is linked to familial dilated cardiomyopathy.